MedTrace Logo

Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure

NCT05598164 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2022-10-28

No results posted yet for this study

Summary

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.

Conditions

  • Chronic Anal Fissure

Interventions

OTHER

Botulinum toxin type A

Patients of main group are treated with injection in internal sphincter botulinum toxin type A. In the control group, the fissure is excised in combination with a injection in internal sphincter botulinum toxin type A.

Sponsors & Collaborators

  • State Scientific Centre of Coloproctology, Russian Federation

    lead OTHER_GOV

Principal Investigators

  • Sergey A. Frolov, Ph.D. · State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-05-01
Completion
2025-05-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05598164 on ClinicalTrials.gov